Inhibition of TGF-β signaling using recombinant human BMP-7 attenuated EndMT and reduced myocardial fibrosis in a mouse MI model, emphasizing the therapeutic potential of targeting this pathway [133]. This evidence concerns the gene TGFB1 and Myocardial fibrosis.